Yesterday, a U.S. Court of Appeals ruled that marijuana should continue to be classified as a schedule-one drug, meaning it has no medical value and the potential for abuse is high.
The decision was a set back for pro-marijuana groups who say the federal government is ignoring scientific evidence that shows pot has some medical value.
Tony Dokoupil, senior writer with Newsweek and the Daily Beast joins the show to discuss the issue.